Cantor Fitzgerald Upgrades Zevra Therapeutics (NASDAQ:ZVRA) to Strong-Buy
Cantor Fitzgerald upgraded shares of Zevra Therapeutics (NASDAQ:ZVRA – Free Report) to a strong-buy rating in a research note issued to investors on Wednesday,Zacks.com reports. Other equities ...
Fintel on MSN17h
Cantor Fitzgerald Initiates Coverage of Acrivon Therapeutics (ACRV) with Overweight Recommendation
Fintel reports that on January 31, 2025, Cantor Fitzgerald initiated coverage of Acrivon Therapeutics (NasdaqGM:ACRV) with a Overweight recommendation. Analyst Price Forecast Suggests 260.44% Upside ...
Hosted on MSN1d
Cantor Fitzgerald Upgrades Lam Research (LRCX)
Fintel reports that on January 30, 2025, Cantor Fitzgerald upgraded their outlook for Lam Research (NasdaqGS:LRCX) from ...
Tesla price target raised to $425 from $365 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Tesla (TSLA) to $425 from $365 and keeps a Neutral rating on the shares. Tesla’s adjusted ...
Lam upgraded to Overweight at Cantor Fitzgerald, says ‘too good to wait’
Cantor Fitzgerald upgraded Lam Research (LRCX) to Overweight from Neutral with a price target of $100, up from $95. The firm had suggested ...
Rochester Sentinel2d
Trump commerce pick says favors broad tariffs, vows tough China stance
Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" ...
Vincennes Sun-Commercial3d
US commerce secretary pick favors sweeping tariffs, hawkish China stance
Donald Trump's commerce secretary nominee said Wednesday that he favors "across-the-board" tariffs and a country-based ...